Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011498

Director gave up 2,471 shares (to pay taxes)

  • Director acquired 8,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Director 2019-02-16 Option exercise +8,125 91,974 D: show line 1 in the form
Schenkein David P Director 2019-02-19 Shares withheld for taxes −2,471 $58.03 $143,392 89,503 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Schenkein David P Director 2019-02-16 Option exercise · Restricted stock units −8,125 16,250 D: show line 3 in the form
Loading xslF345X03/doc4.xml…